AC Immune Ltd (ACIU) Event June 16, 2022, 11:38 UTC (80% Positive) AC Immune Ltd (ACIU) Announces Clinical Development Update (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 5:31 p.m. 🌍 AC Immune Ltd (ACIU) - Form 6-K Filing Filing Date: 2022-06-16 Accepted: 2022-06-16 07:38:48 Event Type: Clinical Trial Update Event Details: The study evaluated the potential of crenezumab, an investigational medicine, to slow or prevent Alzheimers disease in cognitively unimpaired people who carry a specific genetic mutation which causes early-onset Alzheimers disease. 💼 Business Developments: ✅ Partnership/Collaboration❌ Acquisition Activity: Not reported❌ Licensing Agreement: Not reported✅ Regulatory Milestone❌ Leadership Updates: Not reported 📞 Contact Information: Phone: 609 516 5761Email: saoyuth.nidh@acimmune.com
🌍 AC Immune Ltd (ACIU) - Form 6-K Filing
Filing Date: 2022-06-16
Accepted: 2022-06-16 07:38:48
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: